Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Sitari Pharmaceuticals
Sitari Pharmaceuticals
Reports Graph
Drugs targeting the Transglutaminase 2 (TG2) pathway to treat multiple disease indications, with an initial focus in celiac disease
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next